Development of Stereoselective Method for the Quantification of Stereoisomers and Geometrical Isomer of Pitavastatin Calcium by Enhanced Approach

2014 ◽  
Vol 77 (13-14) ◽  
pp. 901-912 ◽  
Author(s):  
B. Hariram ◽  
R. Suresh Kumar ◽  
Anireddy Jayashree ◽  
Dama Venugopala Rao ◽  
Rajeswar Reddy Sagyam ◽  
...  
1994 ◽  
Vol 43 (3) ◽  
pp. 509-510
Author(s):  
S. Z. Sultanov ◽  
V. A. Dokichev ◽  
E. E. Shults ◽  
U. M. Dzhemilev ◽  
G. A. Tolstikov ◽  
...  

1993 ◽  
Vol 34 (45) ◽  
pp. 7197-7200 ◽  
Author(s):  
Raymond S. Gross ◽  
Shujaath Mehdi ◽  
James R. McCarthy

2015 ◽  
Vol 78 (15-16) ◽  
pp. 1017-1029 ◽  
Author(s):  
B. Hariram ◽  
R. Suresh Kumar ◽  
Anireddy Jaya Shree ◽  
Dama Venugopala Rao ◽  
L. Kalyanaraman ◽  
...  

Science ◽  
1973 ◽  
Vol 181 (4100) ◽  
pp. 661-663 ◽  
Author(s):  
J. A. Klun ◽  
O. L. Chapman ◽  
K. C. Mattes ◽  
P. W. Wojtkowski ◽  
M. Beroza ◽  
...  

ChemInform ◽  
2010 ◽  
Vol 26 (5) ◽  
pp. no-no
Author(s):  
S. Z. SULTANOV ◽  
V. A. DOKICHEV ◽  
E. E. SHULTS ◽  
U. M. DZHEMILEV ◽  
G. A. TOLSTIKOV ◽  
...  

2020 ◽  
Vol 61 (6) ◽  
pp. 911-932 ◽  
Author(s):  
M. John Chapman ◽  
Alexina Orsoni ◽  
Ricardo Tan ◽  
Natalie A. Mellett ◽  
Anh Nguyen ◽  
...  

Atherogenic LDL particles are physicochemically and metabolically heterogeneous. Can bioactive lipid cargo differentiate LDL subclasses, and thus potential atherogenicity? What is the effect of statin treatment? Obese hypertriglyceridemic hypercholesterolemic males [n = 12; lipoprotein (a) <10 mg/dl] received pitavastatin calcium (4 mg/day) for 180 days in a single-phase unblinded study. The lipidomic profiles (23 lipid classes) of five LDL subclasses fractionated from baseline and post-statin plasmas were determined by LC-MS. At baseline and on statin treatment, very small dense LDL (LDL5) was preferentially enriched (up to 3-fold) in specific lysophospholipids {LPC, lysophosphatidylinositol (LPI), lysoalkylphosphatidylcholine [LPC(O)]; 9, 0.2, and 0.14 mol per mole of apoB, respectively; all P < 0.001 vs. LDL1-4}, suggesting elevated inflammatory potential per particle. In contrast, lysophosphatidylethanolamine was uniformly distributed among LDL subclasses. Statin treatment markedly reduced absolute plasma concentrations of all LDL subclasses (up to 33.5%), including LPC, LPI, and LPC(O) contents (up to −52%), consistent with reduction in cardiovascular risk. Despite such reductions, lipotoxic ceramide load per particle in LDL1-5 (1.5–3 mol per mole of apoB; 3–7 mmol per mole of PC) was either conserved or elevated. Bioactive lipids may constitute biomarkers for the cardiometabolic risk associated with specific LDL subclasses in atherogenic dyslipidemia at baseline, and with residual risk on statin therapy.


Sign in / Sign up

Export Citation Format

Share Document